🇺🇸 FDA
Patent

US 10316371

Screening methods for identifying specific Staphylococcus aureus inhibitors

granted A61KA61K31/137A61K31/192

Quick answer

US patent 10316371 (Screening methods for identifying specific Staphylococcus aureus inhibitors) held by TRANA DISCOVERY, INC. expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TRANA DISCOVERY, INC.
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/137, A61K31/192, A61K31/352, A61K31/424